ArticleHuman vaccines & immunotherapeutics2021

Formulation development of a live attenuated human rotavirus (RV3-BB) vaccine candidate for use in low- and middle-income countries.

Prashant Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.